Biology Reference
In-Depth Information
Pantaleo G, Soudeyns H, Demarest JF, Vaccarezza M, Graziosi C, Paolucci S, Daucher M, Cohen
OJ, Denis F, Biddison W, Sekaly RP, Fauci AS. 1997a. Evidence for rapid disappearance of
initially expanded HIV-speci®c CD8
T cell clones during primary infection. Proc Natl Acad Sci
USA 94: 9848±9853.
Pantaleo G, Demarest JF, Schacker T, Vaccarezza M, Cohen OJ, Daucher M, Graziosi C,
Schnittman SS, Quinn TJ, Shaw GM, Perrin L, Tambussi G, Lazzarin A, Sekaly RP, Soudeyns
H, Corey L, Fauci AS. 1997b. The qualitative nature of the primary immune response to HIV
infection is a prognosticator of disease progression independent of the initial level of plasma
viremia. Proc Natl Acad Sci USA 94: 254±258.
Pantaleo G, Soudeyns H, Demarest JF, Vaccarezza M, Graziosi C, Paolucci S, Daucher M, Cohen
OJ, Denis F, Biddison W, Sekaly RP, Fauci AS. 1997c. Accumulation of human immuno-
de®ciency virus-speci®c cytotoxic T lymphocytes away from the predominant site of virus repli-
cation during primary infection. Eur J Immunol 27: 3166±3173.
Panzara MA, Gussoni E, Steinman L, Oksenberg JR. 1992. Analysis of the T cell repertoire using
the PCR and speci®c oligonucleotide primers. Biotechniques 12: 728±736.
Pitcher CJ, Quittner C, Peterson DM, Connors M, Koup RA, Maino VC, Picker LJ. 1999. HIV-1-
speci®c CD4
T cells are detectable in most individuals with active HIV-1 infection, but decline
with prolonged viral suppression. Nat Med 5: 518±525.
Posnett DN, Wang CY, Friedman SM. 1986. Inherited polymorphism of the human T-cell antigen
receptor detected by a monoclonal antibody. Proc Natl Acad Sci USA 83: 7888±7892.
Posnett DN, Kabak S, Hodtsev AS, Goldberg EA, Asch A. 1993. TCR-Vb subsets are not prefer-
entially deleted in AIDS. AIDS 7: 625±631.
Posnett DN, Romagne F, Necker A, Kotzin BL, Sekaly RP. 1996. First human TcR monoclonal
antibody workshop. Immunologist 4: 5±8.
Pullen AM, Wade T, Marrack P, Kappler JW. 1990. Identi®cation of the region of T cell receptor b
chain that interacts with the self-superantigen Mls-1a. Cell 61: 1365±1374.
Pullen AM, Bill J, Kubo RT, Marrack P, Kappler JW. 1991. Analysis of the interaction site for the
self superantigen Mls-1a on T cell receptor Vb. J Exp Med 173: 1183±1192.
Ramsden DA, Paul TT, Gellert M. 1997. Cell-free V( D)J recombination. Nature 388: 488±491.
Rebai N, Pantaleo G, Demarest JF, Ciurli C, Soudeyns H, Adelsberger JW, Vaccarezza M, Walker
RE, Sekaly RP, Fauci AS. 1994. Analysis of the T-Cell receptor b-chain variable-region (Vb)
repertoire in monozygotic twins discordant for human immunode®ciency virus: evidence for
perturbations of speci®c Vb segments in CD4
T cells of the virus-positive twin. Proc Natl Acad
Sci USA 91: 1529±1533.
Reinherz EL, Tan K, Tang L, Kern P, Liu JH, Xiong Y, Hussey RE, Smolyar A, Hare B, Zhang R,
Joachimiak A, Chang HC, Wagner G, Wang JH. 1999. The crystal structure of a T cell receptor
in complex with peptide and MHC class II. Science 286: 1913±1921.
Rock EP, Sibbald PR, Davis MM, Chien YH. 1994. CDR3 length in antigen-speci®c immune re-
ceptors. J Exp Med 179: 323±328.
Rosenberg ES, Billingsley JM, Caliendo AM, Boswell SL, Sax PE, Kalams SA, Walker BD. 1997.
Vigorous HIV-1-speci®c CD4
T cell responses associated with control of viremia. Science 278:
1447±1450.
Rosenberg ES, Altfeld M, Poon SH, Phillips MN, Wilkes BM, Eldridge RL, Robbins GK,
D'Aquila RT, Gouldre PJR, Walker BD. 2000. Immune control of HIV-1 after early treatment
of acute infection. Nature 407: 523±526.
Rowen L, Koop BF, Hood L. 1996. The complete 685-kilobase DNA sequence of the human b T
cell receptor locus. Science 272: 1755±1762.
Rowland-Jones S, Nixon DF, Aldhous MC, Gotch F, Ariyoshi K, Hallam N, Kroll JS, Froebel K,
McMichael A. 1993. HIV-speci®c cytotoxic T-cell activity in an HIV-exposed but uninfected
infant. Lancet 341: 860±861.
